Westfield Capital Management Company, L.P. 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-05 12:01 pm Sale | 2023-06-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Westfield Capital Management Company, L.P. | 0 0.000% | -8,145,674 (Position Closed) | Filing |
| 2022-02-01 1:23 pm Sale | 2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Westfield Capital Management Company, L.P. | 8,145,674 4.980% | -342,368 (-4.03%) | Filing |
| 2021-01-06 7:25 pm Purchase | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Westfield Capital Management Company, L.P. | 8,488,042 5.300% | 8,488,042 (New Position) | Filing |